Scholarlink

Fibroblast activation protein (FAP), scarcely expressed by fibroblasts in normal tissue, is highly expressed in activated fibroblasts, which are commonly associated with chronic inflammation and in cancer microenvironment. FAP is being explored as a therapeutic target for the treatment of fibrotic pathology. Here, we describe an FAP mRNA encapsulated in lipid nanoparticles (FAP mRNA-LNP) for use as a vaccine to attenuate the severity of experimental arthritis. This FAP mRNA-LNP vaccine may have a broader application, such as therapy for cancer and other fibrotic conditions.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Targeting Fibrosis in Arthritis Using mRNA Vaccine-Based Approach

  • 实验方案

  • 发表日期：

    2026年

查看全文
  • Qiang Xu,
  • Xiaofei Shi,
  • Xiaowei Zhang,
  • Pingfang Song,
  • Cong-Qiu Chu

摘要

Fibroblast activation protein (FAP), scarcely expressed by fibroblasts in normal tissue, is highly expressed in activated fibroblasts, which are commonly associated with chronic inflammation and in cancer microenvironment. FAP is being explored as a therapeutic target for the treatment of fibrotic pathology. Here, we describe an FAP mRNA encapsulated in lipid nanoparticles (FAP mRNA-LNP) for use as a vaccine to attenuate the severity of experimental arthritis. This FAP mRNA-LNP vaccine may have a broader application, such as therapy for cancer and other fibrotic conditions.